`
`DTX 389: Klohs et al., Inhibitors of tyrosine kinase. 9 Curr. Opin. Oncol.
`562-568 (1997).................................................................................................. A5412
`
`DTX 414: Mendelsohn J., Growth-factor receptors as a target for therapy in
`Lung Cancer 364-378 (Jack A. Roth, et al., eds. 1993) ................................... A5419
`
`DTX 427: OSI Pharmaceuticals, Inc. Annual 10-K Report 1998, SEC
`Certified Copy ................................................................................................... A5437
`
`DTX 428: Patent Evaluation: Quinazoline tyrosine kinase inhibitors, Patent
`Evaluations: Oncologic, Endocrine Metabolic 425-427 (1993) ....................... A5501
`
`DTX 433: Perez-Soler et al., Growth-Factor Receptors as a Target for
`Therapy in Lung Cancer 309-341 (Jack A. Roth et al., 2d ed. 1998) .............. A5504
`
`DTX 443: Rusch et al., The Epidermal Growth Factor Receptor and its
`Ligands as Therapeutic Targets in Human Tumors. 7 Cytokine & Growth
`Factor Reviews 133-141 (1996) ....................................................................... A5540
`
`DTX 572: Burgess et al., Enantioselective Esterifications of Unsaturated
`Alcohols Mediated by a Lipase Prepared from Pseudomonas sp. 113 J. Am.
`Chem. Soc. pp. 6129-39 (1991) ........................................................................ A5559
`
`DTX 589: Palmer et al., Two types of cage convulsant action at the GABA-
`gated chloride channel. 42 Toxicology Letters, pp. 117-122 (1988) ............... A5570
`
`DTX 740: USPTO Patent Full-Text and Image Database,
`"aclm/((pharmaceutical or pharmaceutically) and (ethynyl or alkynyl)) and
`isd/01/01/1976->06/30/1994," "http://patft.uspto.gov/netahtml/PTO/search-
`adv.htm” ............................................................................................................ A5628
`
`DTX 772: Barker et al., EP 0 520 722 A1 ....................................................... A5707
`
`PTX 075: Ortiz de Montellano P. and Kunze K., Self-catalyzed inactivation
`of hepatic cytochrome P-450 by ethynyl substrates. J. Bio. Chem. (1980)
`255:5578-5585 .................................................................................................. A5728
`
`PTX 310: Handwritten Notes from Lee Arnold to EGFR Project Team re:
`Zeneca Patent EP 0 56622A Summary ............................................................. A5736
`
`
`APOTEX EX. 1062-001
`
`